122 related articles for article (PubMed ID: 12939732)
1. Ischemia in type 2 diabetes: tissue selectivity of sulfonylureas and clinical implications.
Wascher TC; Boes U
Metabolism; 2003 Aug; 52(8 Suppl 1):3-5. PubMed ID: 12939732
[TBL] [Abstract][Full Text] [Related]
2. Sulfonylurea sensitivity of adenosine triphosphate-sensitive potassium channels from beta cells and extrapancreatic tissues.
Gribble FM; Ashcroft FM
Metabolism; 2000 Oct; 49(10 Suppl 2):3-6. PubMed ID: 11078468
[TBL] [Abstract][Full Text] [Related]
3. Tissue-specific effects of sulfonylureas: lessons from studies of cloned K(ATP) channels.
Ashcroft FM; Gribble FM
J Diabetes Complications; 2000; 14(4):192-6. PubMed ID: 11004427
[TBL] [Abstract][Full Text] [Related]
4. Sulfonylurea derivatives in cardiovascular research and in cardiovascular patients.
Schotborgh CE; Wilde AA
Cardiovasc Res; 1997 Apr; 34(1):73-80. PubMed ID: 9217875
[TBL] [Abstract][Full Text] [Related]
5. Role of sulfonylurea receptor type 1 subunits of ATP-sensitive potassium channels in myocardial ischemia/reperfusion injury.
Elrod JW; Harrell M; Flagg TP; Gundewar S; Magnuson MA; Nichols CG; Coetzee WA; Lefer DJ
Circulation; 2008 Mar; 117(11):1405-13. PubMed ID: 18316485
[TBL] [Abstract][Full Text] [Related]
6. ATP-sensitive potassium channels, transmural ischemia and the ECG implications for the non-insulin dependent diabetic patient?
Wilde AA
Cardiovasc Res; 1996 May; 31(5):688-90. PubMed ID: 8763397
[No Abstract] [Full Text] [Related]
7. Pancreatic and extrapancreatic sulfonylurea receptors.
Panten U; Schwanstecher M; Schwanstecher C
Horm Metab Res; 1992 Dec; 24(12):549-54. PubMed ID: 1478610
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for the interference between nicorandil and sulfonylurea action.
Reimann F; Ashcroft FM; Gribble FM
Diabetes; 2001 Oct; 50(10):2253-9. PubMed ID: 11574406
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of the glycaemic effects of sulfonylureas.
Ashcroft FM
Horm Metab Res; 1996 Sep; 28(9):456-63. PubMed ID: 8911983
[TBL] [Abstract][Full Text] [Related]
10. Sulfonylurea and non-sulfonylurea hypoglycemic agents: pharmachological properties and tissue selectivity.
Nagashima K; Takahashi A; Ikeda H; Hamasaki A; Kuwamura N; Yamada Y; Seino Y
Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S75-8. PubMed ID: 15563985
[TBL] [Abstract][Full Text] [Related]
11. Sulfonylurea stimulation of insulin secretion.
Proks P; Reimann F; Green N; Gribble F; Ashcroft F
Diabetes; 2002 Dec; 51 Suppl 3():S368-76. PubMed ID: 12475777
[TBL] [Abstract][Full Text] [Related]
12. Sulfonylureas and mortality in diabetic patients after myocardial infarction.
Brady PA; Al-Suwaidi J; Kopecky SL; Terzic A
Circulation; 1998 Feb; 97(7):709-10. PubMed ID: 9495313
[No Abstract] [Full Text] [Related]
13. Late complications of diabetes mellitus: risk factors in patients on sulfonylureas for more than 10 years.
Hoshi M; Fujita S
Jpn J Med; 1991; 30(6):616-7. PubMed ID: 1798228
[No Abstract] [Full Text] [Related]
14. The sulfonylurea controversy: more questions from the heart.
Brady PA; Terzic A
J Am Coll Cardiol; 1998 Apr; 31(5):950-6. PubMed ID: 9561992
[TBL] [Abstract][Full Text] [Related]
15. ATP-modulated K+ channels sensitive to antidiabetic sulfonylureas are present in adenohypophysis and are involved in growth hormone release.
Bernardi H; De Weille JR; Epelbaum J; Mourre C; Amoroso S; Slama A; Fosset M; Lazdunski M
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1340-4. PubMed ID: 8433992
[TBL] [Abstract][Full Text] [Related]
16. Differential sensitivity of beta-cell and extrapancreatic K(ATP) channels to gliclazide.
Gribble FM; Ashcroft FM
Diabetologia; 1999 Jul; 42(7):845-8. PubMed ID: 10440127
[TBL] [Abstract][Full Text] [Related]
17. [Sulfonylurea drugs for type 2 diabetes].
Toyota T
Nihon Rinsho; 2002 Sep; 60 Suppl 9():339-45. PubMed ID: 12387015
[No Abstract] [Full Text] [Related]
18. Ischemic heart disease in type 2 diabetes.
Otel I; Ledru F; Danchin N
Metabolism; 2003 Aug; 52(8 Suppl 1):6-12. PubMed ID: 12939733
[TBL] [Abstract][Full Text] [Related]
19. Operative condition-dependent response of cardiac ATP-sensitive K+ channels toward sulfonylureas.
Brady PA; Alekseev AE; Terzic A
Circ Res; 1998 Feb; 82(2):272-8. PubMed ID: 9468198
[TBL] [Abstract][Full Text] [Related]
20. Sulfonylurea and the Heart: Theoretically a Compounded Question from a Pathophysiological Perspective.
Farahani P
J Popul Ther Clin Pharmacol; 2016 Sep; 23(3):e193-e195. PubMed ID: 27783474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
